ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ)

$3.76 0.24 (6.8182%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 86

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) News Sources

Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026

17-04-2026

yahoo.com

Zentalis (ZNTL) Locks In Its Cancer Drug Dose; Jefferies Raises the Target

20-04-2026

yahoo.com

Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer

21-04-2026

yahoo.com

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01-05-2026

yahoo.com

Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

05-05-2026

yahoo.com

Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress

12-05-2026

yahoo.com

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

13-05-2026

yahoo.com

Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026

21-05-2026

yahoo.com

Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy

27-05-2026

yahoo.com

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01-06-2026

yahoo.com

ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) Sentiment Trend

0 25 50 75 100 85 93 88 80 86 84 89 79 88 83 17-04-2026 20-04-2026 21-04-2026 01-05-2026 05-05-2026 12-05-2026 13-05-2026 21-05-2026 27-05-2026 01-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) FAQs

toggle

What is the current price of ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ)?

The current price of ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) is $3.76.


toggle

ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) absolute price change since previous trading day?

The absolute price change of ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) since the previous trading day is $0.24.


toggle

ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) percentage price change since previous trading day?

The percentage price change of ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) since the previous trading day is 6.8182%.


toggle

What is the most recent average sentiment score for ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ)?

The most recent average sentiment score for ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) is 86 out of 100.


toggle

What is the most recent average sentiment for ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ)?

The most recent sentiment for ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) is .


SEC-8K** Filing Available For ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.